Chinese robot maker Unitree Robotics has won regulatory approval for a Shanghai listing through which it plans to raise 4.2 billion yuan, or about $619.4 million, moving it closer to what is likely to be one of China’s most closely watched technology IPOs this year. China’s securities regulator approved the Hangzhou-based company’s application to list on the STAR Market, Shanghai’s technology board, in a Thursday notice; the approval is valid for 12 months. Unitree plans to sell at least 40.45 million shares but has not yet set a launch date or price range. YourDailyAnalysis notes that the approval alone doesn’t fix a valuation – the market will do that once pricing is set – but it does clear the single biggest procedural hurdle standing between Unitree and a public listing.
The timing sits inside a broader thaw in China’s onshore listing market. A-share IPOs across the Shanghai, Shenzhen and Beijing exchanges raised $7.7 billion in the first half of the year, up 64.4% from the same period a year earlier, according to LSEG data. China Resources New Energy supplied the most visible evidence of that momentum on Thursday, when its Shenzhen shares more than doubled on debut after the wind and solar company raised 24.5 billion yuan – Asia’s largest IPO so far this year. YourDailyAnalysis reads Unitree’s approval against that backdrop as confirmation that Chinese regulators are actively re-opening the IPO pipeline for capital-intensive technology names, not clearing a single company as an isolated exception.
What Unitree actually makes is worth stating plainly, since the company’s name has circulated widely in humanoid-robotics coverage without much detail on its product mix. The company builds humanoid robots, four-legged robots and robot components. Its prospectus states that IPO proceeds will fund robot artificial intelligence model research, robot body research, new product development, and a smart robot manufacturing base. That allocation matters for how investors should read the raise: this is not primarily a capacity-expansion IPO, it is an R&D-and-manufacturing-buildout IPO, which shifts the investment thesis toward Unitree’s ability to keep pace on the AI-model side of humanoid robotics rather than simply scaling existing hardware production.
The strategic backdrop is where the more significant story sits. Unitree’s listing will function as a test of investor demand for China’s robotics sector broadly, which Beijing has positioned as central to its push to deploy AI-driven machines across factories, homes and public spaces. A strong debut would validate that policy priority in a way that state backing alone cannot; a weak one would raise questions about whether investor enthusiasm for humanoid robotics, high nearly everywhere in 2025 and 2026, has already been priced into China’s most prominent private-sector players before they even reach public markets.
The counter-consideration is valuation risk once pricing is finally set. Humanoid robotics as a category has drawn comparisons to the AI infrastructure buildout in the U.S. – heavy capital commitment against a commercial timeline that remains largely unproven at scale. Unitree has built a reputation for capable, relatively low-cost humanoid and quadruped hardware, but the prospectus’s emphasis on AI model research signals the company itself views its current hardware lead as necessary but not sufficient. YourDailyAnalysis takes the position that the IPO’s eventual pricing will be the real signal of whether investors are backing Unitree’s hardware track record or its unproven AI ambitions – and those two bets carry very different risk profiles.
Watch for the launch date and price range, which Unitree has not yet disclosed, and for how the stock trades against China Resources New Energy’s post-debut performance as a reference point. Your Daily Analysis expects the listing to draw outsized retail and institutional attention regardless of pricing, simply because a successful Unitree debut would be read globally as a proxy for how seriously public markets are willing to value China’s humanoid-robotics ambitions.
